Concepedia

Tina Colombo

TC

Statistics

Publications

49

Citations

2K

H-Index

25

Active since

1975

Affiliations

Mario Negri Institute for Pharmacological Research(Current)

University of Leicester

PharmaMar (Spain)

Tina Colombo is an author at Mario Negri Institute for Pharmacological Research specializing in pharmacology, chemotherapy, and medicine.

Publications per year

1975–2008

49

Publications

49

Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer.

Tinya J. Abrams, Lesley Murray, Enrico Pesenti et al. · PubMed · 2003 · 252 citations

, , +17

Doxorubicin pharmacokinetics: Macromolecule binding, metabolism, and excretion in the context of a physiologic model

Daniel L. Gustafson, Jeffrey C. Rastatter, Tina Colombo et al. · Journal of Pharmaceutical Sciences · 2002 · 103 citations

, , +16

The combination of yondelis and cisplatin is synergistic against human tumor xenografts

Maurizio D’Incalci, Tina Colombo, Paolo Ubezio et al. · European Journal of Cancer · 2003 · 91 citations

, , +9

Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies

Riccardo Riccardi, Daniela Meco, Tina Colombo et al. · Cancer Chemotherapy and Pharmacology · 2003 · 76 citations

, , +11

IDN5109, a taxane with oral bioavailability and potent antitumor activity.

Maria Nicoletti, Tina Colombo, Cosmo Rossi et al. · PubMed · 2000 · 74 citations

, , +16

1–5 of 49